Suzuken Co (TSE:9987) PE Ratio without NRI: 12.40 (As of Jul. 05, 2026) — 26% Below Median


TSE:9987 Suzuken Co Ltd TSE:9987
79 GF Score
Price 円4,950.00
GF Value 円5,910.76
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Suzuken Co PE Ratio without NRI?

Suzuken Co TSE:9987 +0.53% 79 PE Ratio without NRI is 12.40 as of Jul. 05, 2026, which is 26% below its 10-year median of 16.69. GuruFocus rates TSE:9987 with a GF Score™ of 79/100 and a GF Value™ of 円5,910.76 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 87 Medical Distribution companies, Suzuken Co ranks better than 63.22% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-05), Suzuken Co's share price is 円4950.00. Suzuken Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円399.35. Therefore, Suzuken Co's PE Ratio without NRI for today is 12.40.

During the past 13 years, Suzuken Co's highest PE Ratio without NRI was 31.86. The lowest was 10.42. And the median was 16.69.

Suzuken Co's EPS without NRI for the three months ended in Mar. 2026 was 円108.11. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円399.35.

As of today (2026-07-05), Suzuken Co's share price is 円4950.00. Suzuken Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円545.54. Therefore, Suzuken Co's PE Ratio (TTM) for today is 9.07.

Good Sign:

Suzuken Co Ltd stock PE Ratio (=9.07) is close to 10-year low of 8.95.

During the past years, Suzuken Co's highest PE Ratio (TTM) was 47.84. The lowest was 8.95. And the median was 16.07.

Suzuken Co's EPS (Diluted) for the three months ended in Mar. 2026 was 円105.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円545.54.

Suzuken Co's EPS (Basic) for the three months ended in Mar. 2026 was 円105.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円545.54.


Suzuken Co  (TSE:9987) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Suzuken Co PE Ratio without NRI Related Terms


Suzuken Co PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Suzuken Co's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzuken Co PE Ratio without NRI Chart

Suzuken Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.35 11.90 14.36 14.07 15.09

Suzuken Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.07 15.29 15.52 16.98 15.09

TSE:9987 vs MCK, CAH, COR: PE Ratio without NRI Comparison

For the Medical Distribution subindustry, Suzuken Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Suzuken Co's PE Ratio without NRI falls into.


TSE:9987
79GF Score
Suzuken Co Ltd TSE:9987
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzuken Co PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Suzuken Co's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=4950.00/399.351
=12.4

Suzuken Co's Share Price of today is 円4950.00.
Suzuken Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円399.35.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 12.40 mean?
Suzuken Co (TSE:9987) has a PE Ratio without NRI of 12.40 as of Jul. 05, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Suzuken Co and its competitors. This is 26% below median its historical median of 16.69. Over the past decade, Suzuken Co's PE Ratio without NRI has ranged from 10.42 to 31.86. According to the industry distribution chart, Suzuken Co ranks #32 out of 87 companies in the Medical Distribution industry, placing it in the top 36.8%.
Is Suzuken Co's PE Ratio without NRI too high?
Suzuken Co's current PE Ratio without NRI of 12.40 is 26% below median its 10-year median of 16.69. Over the past 10 years, this metric has ranged from a low of 10.42 to a high of 31.86. The Medical Distribution industry median PE Ratio without NRI is 15.78. Suzuken Co's value of 12.40 is 21.4% below this industry median. Based on the distribution chart, Suzuken Co ranks #32 out of 87 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Suzuken Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's PE Ratio without NRI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Suzuken Co ranks #32 out of 87 companies for PE Ratio without NRI. This puts Suzuken Co in the upper half of its industry. The industry median PE Ratio without NRI is 15.78. Suzuken Co's value of 12.40 is 21.4% below this benchmark. Historically, Suzuken Co's own PE Ratio without NRI has ranged from 10.42 to 31.86 over the past decade. While the company's 10-year median is 16.69 vs. the industry median of 15.78, Suzuken Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Distribution company?
The median PE Ratio without NRI among Medical Distribution companies is 15.78, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzuken Co's current PE Ratio without NRI of 12.40 is 21.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Suzuken Co and its competitors. For the Medical Distribution industry, the median PE Ratio without NRI is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzuken Co's current PE Ratio without NRI is 12.40, which is 26% below median its own 10-year median of 16.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,910.76, compared to a current price of 円4,950.00 — trading 16.3% below its estimated fair value. The current PE Ratio without NRI is 12.40, which is 26% below median its 10-year median of 16.69 and 21.4% below the Medical Distribution industry median of 15.78. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current PE Ratio without NRI is 12.40 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzuken Co (TSE:9987) Overvalued in 2026?

Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued. The current stock price of 円4,950.00 is trading 16.3% below its estimated GF Value™ of 円5,910.76. GuruFocus considers Suzuken Co to be Modestly Undervalued.

Key valuation signals for TSE:9987:

  • PE Ratio without NRI: 12.40 (26% below median its 10-year median of 16.69)
  • GF Value™: 円5,910.76 vs. price of 円4,950.00 (16.3% below fair value)
  • GF Score™: 79/100 with 1 warning sign
  • Industry Position: 21.4% below the Medical Distribution median (#32 of 87)

No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suzuken Co Business Description

Other Exchanges ZU1:Germany
Address 8 Higashikatabatacho, Higashi Ward, Aichi Prefecture, Nagoya, JPN, 461-8701
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score

Get the complete analysis for TSE:9987

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,950.00
Price
円5,910.76
GF Value